Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
CD19-Car T Cell Therapy for the Treatment of Older Adults With Acute Lymphoblastic Leukemia in First Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
- Status
- RECRUITING
- Phase
- PHASE1
HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Natural Killer(NK) Cell Therapy in r/r AML
- Status
- RECRUITING
- Phase
- PHASE1
Natural Killer (NK) Cell Therapy Targeting CD33 in Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
EBV CAR-T Cells for Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
TIL Cells for the Treatment of the Advanced Solid Tumors Patients
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
CD30 CAR for CD30+ NSGCT
- Status
- COMPLETED
- Phase
- PHASE2
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
TRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2